American Portfolios Advisors Astrazeneca PLC Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, American Portfolios Advisors holds 25,775 shares of AZN stock, worth $1.93 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

25,775

Holding current value

$1.93 Million

% of portfolio

0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$53.02 - $135.75 $1.37 Million - $3.5 Million	25,775 New	25,775 $1.41 Billion
Q2 2022 Mar 20, 2023	BUY	$59.26 - $71.14 $90,371 - $108,488	1,525 Added 5.92%	27,300 $1.8 Billion
Q1 2022 Mar 21, 2023	BUY	$55.72 - $67.12 $86,867 - $104,640	1,559 Added 6.05%	27,334 $1.81 Billion
Q4 2021 Mar 21, 2023	SELL	$54.02 - $63.83 $171,351 - $202,468	-3,172 Reduced 12.31%	22,603 $1.32 Billion
Q3 2021 Mar 22, 2023	SELL	$55.56 - $60.79 $423,256 - $463,098	-7,618 Reduced 29.56%	18,157 $1.09 Billion
Q2 2021 Mar 22, 2023	SELL	$48.42 - $60.18 $578,764 - $719,331	-11,953 Reduced 46.37%	13,822 $828 Million
Q1 2021 Mar 22, 2023	SELL	$47.16 - $54.44 $590,914 - $682,133	-12,530 Reduced 48.61%	13,245 $659 Million
Q4 2020 Mar 22, 2023	SELL	$48.52 - $58.02 $515,816 - $616,810	-10,631 Reduced 41.25%	15,144 $757 Million
Q3 2020 Mar 22, 2023	SELL	$53.07 - $61.1 $312,104 - $359,329	-5,881 Reduced 22.82%	19,894 $1.09 Billion
Q2 2020 Mar 24, 2023	BUY	$43.1 - $55.31 $349,023 - $447,900	8,098 Added 66.04%	20,360 $1.08 Billion
Q1 2020 Mar 24, 2023	SELL	$37.79 - $51.33 $510,656 - $693,622	-13,513 Reduced 52.43%	12,262 $548 Million
Q4 2019 Mar 24, 2023	SELL	$42.46 - $50.46 $509,562 - $605,570	-12,001 Reduced 46.56%	13,774 $687 Million
Q3 2019 Mar 24, 2023	SELL	$40.12 - $45.47 $31,534 - $35,739	-786 Reduced 5.43%	13,683 $610 Million
Q2 2019 Mar 24, 2023	SELL	$37.28 - $41.68 $421,487 - $471,234	-11,306 Reduced 43.86%	14,469 $597 Million
Q1 2019 Mar 24, 2023	BUY	$35.49 - $43.02 $123,718 - $149,967	3,486 Added 30.97%	14,741 $596 Million
Q4 2018 Mar 24, 2023	SELL	$36.86 - $41.49 $36,417 - $40,992	-988 Reduced 8.07%	11,255 $427 Million
Q3 2018 Mar 24, 2023	SELL	$34.76 - $39.72 $470,372 - $537,491	-13,532 Reduced 52.5%	12,243 $484 Million
Q2 2018 Mar 24, 2023	SELL	$34.55 - $37.05 $3,040 - $3,260	-88 Reduced 0.7%	12,529 $440 Million
Q1 2018 Mar 24, 2023	SELL	$32.97 - $36.63 $433,819 - $481,977	-13,158 Reduced 51.05%	12,617 $441 Million
Q4 2017 Mar 24, 2023	SELL	$32.09 - $34.78 $477,178 - $517,178	-14,870	10,905 $378 Million

Others Institutions Holding AZN

# of Institutions

1,368

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $232B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Astrazeneca PLC Transaction History